Impact BioMedical Inc. (IBO)

CIK 0001834105 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q2-2026 —
Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —
Q3-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Condensed Consolidated Statements of Stockholder's Equity (unaudited)
—
Condensed Consolidated Statements of Stockholders' (deficit) Equity (unaudited)
—
Consolidated Statements of Cash Flows
Consolidated Statements of Changes In Stockholders' Equity
—
Notes
Acquisition
—
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
—
Description of Business
—
Financial Instruments
Goodwill
Income Taxes
—
Insider Trading Arrangements
—
Intangible Assets
Inventory
Investments
Nature of Operations and Basis of Presentation
—
Note Payable, Related Party
Notes Receivable
Pay Vs Performance Disclosure
—
Prepaid Expenses and Other Current Assets
Property Plant and Equipment and Investment In Real Estate, Net
—
Property, Plant and Equipment, Net
Related Party Transactions
Revision of Financial Statements
—
Short Term Debt
—
Stockholders Equity
Subsequent Events
Summary of Significant Accounting and Reporting Policies
—
Summary of Significant Accounting Policies
—
Supplemental Cash Flow Information